Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies. Our valuation framework helps you find stocks with the right balance of growth and value characteristics.
Henry Schein Inc. (HSIC), a global provider of healthcare products, services, and solutions to dental, medical, and veterinary practices, is trading at a current price of $78.83 as of April 18, 2026, posting a 2.10% gain on the day. This analysis breaks down recent market context for HSIC, well-tested technical support and resistance levels, and potential near-term trading scenarios, with no investment recommendations included. Recent price action for the firm has been driven by a mix of broader
Is Henry Schein (HSIC) stock fairly priced today (+2.10%) 2026-04-18 - Rating Change
HSIC - Stock Analysis
4513 Comments
1576 Likes
1
Olvis
Returning User
2 hours ago
This effort deserves a standing ovation. 👏
👍 142
Reply
2
Pecola
Insight Reader
5 hours ago
Free US stock comparative valuation tools and peer analysis to identify mispriced securities and find value opportunities in the market. We help you understand relative value across different metrics and time periods for better investment decisions. Our platform offers peer comparisons, relative valuation, and spread analysis for comprehensive valuation coverage. Find mispriced stocks with our comprehensive valuation tools and expert analysis for smarter investment selection.
👍 195
Reply
3
Maxson
Senior Contributor
1 day ago
Nicely highlights both opportunities and potential challenges.
👍 116
Reply
4
Haidi
Active Contributor
1 day ago
Anyone else trying to catch up?
👍 205
Reply
5
Kurston
Regular Reader
2 days ago
Today’s rally is supported by strong investor sentiment.
👍 267
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.